Topics

Behçet's Disease: Is Ustekinumab a Viable Treatment?

10:30 EDT 1 May 2019 | MedPageToday

(MedPage Today) -- Complete responses seen in 60% and 89% of treated patients at weeks 12 and 24, respectively

Original Article: Behçet's Disease: Is Ustekinumab a Viable Treatment?

NEXT ARTICLE

More From BioPortfolio on "Behçet's Disease: Is Ustekinumab a Viable Treatment?"

Quick Search